Literature DB >> 30711669

How long does it take to complete outpatient substance use disorder treatment? Disparities among Blacks, Hispanics, and Whites in the US.

Jeremy Mennis1, Gerald J Stahler2, Samir Abou El Magd3, David A Baron4.   

Abstract

This research investigates racial and ethnic disparities in outpatient substance use disorder treatment completion and duration in treatment, for different substances, across the US, using the national 2014 Treatment Episode Dataset-Discharge (TEDS-D) data set. Moderated fixed effects logistic regression models assessed effects of race/ethnicity on length of stay in treatment and treatment completion for different substances of use. Moderated models also assessed the differential effect of length of stay on treatment completion among Blacks, Hispanics, and Whites. While Blacks and Hispanics both have significantly lower treatment completion rates than Whites, treatment duration is substantially similar across the three groups. Blacks and Hispanics generally take longer to complete treatment than Whites, though this varies by substance for Hispanics. Disparities in treatment completion persist even after controlling for treatment duration. These results indicate that observed racial and ethnic disparities in treatment completion are not due to differences in length of stay in treatment. Economic, cultural, accessibility, or, potentially, discriminatory, factors may suppress the likelihood of treatment completion for minorities and result in longer treatment durations required for completion. Recognition by treatment providers of the unique challenges to treatment completion faced by minorities may enhance treatment outcomes for minorities in the US.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disparity; Length of stay; Outpatient; Race; Treatment completion; Treatment duration

Mesh:

Year:  2019        PMID: 30711669     DOI: 10.1016/j.addbeh.2019.01.041

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  10 in total

1.  Medication for opioid use disorder treatment and specialty outpatient substance use treatment outcomes: Differences in retention and completion among opioid-related discharges in 2016.

Authors:  Melanie S Askari; Silvia S Martins; Pia M Mauro
Journal:  J Subst Abuse Treat       Date:  2020-05-11

2.  The impact of self-help groups on successful substance use treatment completion for opioid use: An intersectional analysis of race/ethnicity and sex.

Authors:  Madeline R Stenersen; Kathryn Thomas; Cara Struble; Kelly E Moore; Catherine Burke; Sherry McKee
Journal:  J Subst Abuse Treat       Date:  2021-11-20

3.  Technology-Based Interventions in Substance Use Treatment to Promote Health Equity Among People Who Identify as African American/Black, Hispanic/Latinx, and American Indian/Alaskan Native: Protocol for a Scoping Review.

Authors:  Emily G Hichborn; Sarah K Moore; Phoebe R Gauthier; Nico O Agosti; Kathleen D Bell; Jesse S Boggis; Chantal A Lambert-Harris; Elizabeth C Saunders; Avery M Turner; Bethany M McLeman; Lisa A Marsch
Journal:  JMIR Res Protoc       Date:  2022-05-17

4.  Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.

Authors:  George Pro; Jeff Utter; Shane Haberstroh; Julie A Baldwin
Journal:  Drug Alcohol Depend       Date:  2020-03-07       Impact factor: 4.492

Review 5.  Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism.

Authors:  Hortensia Amaro; Mariana Sanchez; Tara Bautista; Robynn Cox
Journal:  Neuropharmacology       Date:  2021-03-11       Impact factor: 5.250

Review 6.  An Evaluation of Opioid Use in Black Communities: A Rapid Review of the Literature.

Authors:  Ayana Jordan; Myra Mathis; Angela Haeny; Melissa Funaro; Dafna Paltin; Yusuf Ransome
Journal:  Harv Rev Psychiatry       Date:  2021 Mar-Apr 01       Impact factor: 3.732

7.  Substance Use Disorder Detection Rates Among Providers of General Medical Inpatients.

Authors:  Kristin L Serowik; Kimberly A Yonkers; Kathryn Gilstad-Hayden; Ariadna Forray; Paula Zimbrean; Steve Martino
Journal:  J Gen Intern Med       Date:  2020-10-27       Impact factor: 5.128

8.  Gender disparities in opioid treatment progress in methadone versus counseling.

Authors:  Erick Guerrero; Hortensia Amaro; Yinfei Kong; Tenie Khachikian; Jeanne C Marsh
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-06-23

9.  Trends in Adolescent Treatment Admissions for Marijuana in the United States, 2008-2017.

Authors:  Jeremy Mennis
Journal:  Prev Chronic Dis       Date:  2020-11-19       Impact factor: 2.830

10.  Stability in a large drug treatment system: Examining the role of program size and performance on service discontinuation.

Authors:  Erick G Guerrero; Abdullah Alibrahim; Daniel L Howard; Shinyi Wu; Thomas D'Aunno
Journal:  Int J Drug Policy       Date:  2020-09-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.